Benzinga's Top Upgrades, Downgrades For August 19, 2019 - ACM Research (NASDAQ:ACMR), AECOM (NYSE:ACM)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Upgrades

Barclays changed the rating for AECOM (NYSE:ACM) from Underweight to Overweight. AECOM earned $0.72 in the third quarter, compared to $0.62 in the year-ago quarter. The current market cap for AECOM is at $2.7 billion. The stock has a 52-week-high of $38.20 and a 52-week-low of $24.83. AECOM's stock last closed at $32.96 per share.
For Ares Capital Corp (NASDAQ:ARCC), BMO Capital upgraded the stock from Market Perform to Outperform. In the second quarter, Ares Capital showed an EPS of $0.49, compared to $0.39 from the year-ago quarter. The total market value of Ares Capital's outstanding shares is at $7.0 billion. The stock has a 52-week-high of $18.83 and a 52-week-low of $14.50. Ares Capital's stock last closed at $18.64 per share.
Stifel Nicolaus upgraded the stock for Aramark (NYSE:ARMK) from Hold to Buy. Aramark earned $0.47 in the third quarter, compared to $0.48 in the year-ago quarter. The stock has a 52-week-high of $43.70 and a 52-week-low of $25.49. Aramark's stock last closed at $37.09 per share.
Nomura changed the rating for Aramark (NYSE:ARMK) from Neutral to Buy. In the third quarter, Aramark showed an EPS of $0.47, compared to $0.48 from the year-ago quarter. The stock has a 52-week-high of $43.70 and a 52-week-low of $25.49. Aramark's stock last closed at $37.09 per share.
Jefferies upgraded the stock for Ceridian HCM Holding Inc (NYSE:CDAY) from Hold to Buy. Ceridian HCM Holding earned $0.12 in the second quarter, compared to ($0.05) in the year-ago quarter. The total market value of Ceridian HCM Holding's outstanding shares is at $6.9 billion. The stock has a 52-week-high of $56.10 and a 52-week-low of $31.39. Ceridian HCM Holding's stock last closed at $50.68 per share.
Morgan Stanley changed the rating for CNH Industrial NV (NYSE:CNHI) from Equal-Weight to Overweight. CNH Industrial earned $0.31 in the second quarter, compared to $0.24 in the year-ago quarter. The total market value of CNH Industrial's outstanding shares is at $12.4 billion. The stock has a 52-week-high of $12.68 and a 52-week-low of $8.41. CNH Industrial's stock last closed at $8.81 per share.
Citi upgraded the stock for Corteva Inc (NYSE:CTVA) from Neutral to Buy. Corteva earned $1.42 in the second quarter, compared to $1.56 in the year-ago quarter. Corteva's market cap stands at $22.1 billion. The stock has a 52-week-high of $32.78 and a 52-week-low of $24.35. Corteva's stock last closed at $30.25 per share.
Pivotal Research upgraded the stock for Deckers Outdoor Corp (NYSE:DECK) from Hold to Buy. For the first quarter, Deckers Outdoor had an EPS of ($0.67), compared to year-ago quarter EPS of ($0.98). The total market value of Deckers Outdoor's outstanding shares is at $3.5 billion. The stock has a 52-week-high of $180.75 and a 52-week-low of $101.69. Deckers Outdoor's stock last closed at $134.16 per share.
Imperial Capital changed the rating for Lions Gate Entertainment Corp (NYSE: LGF-B) from In-Line to Outperform. The current market cap for Lions Gate Entertainment is at $4.9 billion.
Raymond James upgraded the stock for ON Semiconductor Corp (NASDAQ:ON) from Market Perform to Strong Buy. ON Semiconductor earned $0.42 in the second quarter, compared to $0.46 in the year-ago quarter. The total market value of ON Semiconductor's outstanding shares is at $9.0 billion. The stock has a 52-week-high of $23.54 and a 52-week-low of $14.55. ON Semiconductor's stock last closed at $17.54 per share.
MKM Partners upgraded the stock for Range Resources Corp (NYSE:RRC) from Neutral to Buy. In the second quarter, Range Resources showed an EPS of $0.02, compared to $0.20 from the year-ago quarter. The current market cap for Range Resources is at $3.8 billion. The stock has a 52-week-high of $18.59 and a 52-week-low of $3.76. Range Resources's stock last closed at $4.11 per share.
SVB Leerink changed the rating for Solid Biosciences Inc (NASDAQ:SLDB) from Market Perform to Outperform. In the second quarter, Solid Biosciences showed an EPS of ($0.76), compared to ($0.52) from the year-ago quarter. The total market value of Solid Biosciences's outstanding shares is at $321.5 million. The stock has a 52-week-high of $54.54 and a 52-week-low of $4.32. Solid Biosciences's stock last closed at $8.81 per share.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Downgrades

Mizuho changed the rating for Amgen Inc (NASDAQ:AMGN) from Buy to Neutral. For the second quarter, Amgen had an EPS of $3.97, compared to year-ago quarter EPS of $3.83. Amgen's market cap stands at $108.8 billion. The stock has a 52-week-high of $211.90 and a 52-week-low of $166.30. Amgen's stock last closed at $204.02 per share.
Susquehanna downgraded the stock for Air Products & Chemicals Inc (NYSE:APD) from Positive to Neutral. Air Products & Chemicals earned $2.17 in the third quarter, compared to $1.95 in the year-ago quarter. Air Products & Chemicals's market cap stands at $28.1 billion. The stock has a 52-week-high of $232.47 and a 52-week-low of $148.44. Air Products & Chemicals's stock last closed at $228.78 per share.
JP Morgan changed the rating for Alliance Resource Partners LP (NASDAQ:ARLP) from Overweight to Neutral. Alliance Resource earned $0.44 in the second quarter, compared to $0.63 in the year-ago quarter. The current market cap for Alliance Resource is at $3.4 billion. The stock has a 52-week-high of $20.99 and a 52-week-low of $14.41. Alliance Resource's stock last closed at $14.96 per share.
JP Morgan changed the rating for Peabody Energy Corp (NYSE:BTU) from Overweight to Neutral. For the second quarter, Peabody Energy had an EPS of $0.40, compared to year-ago quarter EPS of $0.93. The stock has a 52-week-high of $44.71 and a 52-week-low of $17.20. Peabody Energy's stock last closed at $19.18 per share.
Credit Suisse downgraded the stock for EnLink Midstream LLC (NYSE:ENLC) from Outperform to Neutral. For the second quarter, EnLink Midstream had an EPS of $0.07, compared to year-ago quarter EPS of $0.15. The current market cap for EnLink Midstream is at $5.0 billion. The stock has a 52-week-high of $17.65 and a 52-week-low of $7.14. EnLink Midstream's stock last closed at $7.75 per share.
For East West Bancorp Inc (NASDAQ:EWBC), BMO Capital downgraded the stock from Outperform to Market Perform. In the second quarter, East West Bancorp showed an EPS of $1.24, compared to $1.18 from the year-ago quarter. East West Bancorp's market cap stands at $7.8 billion. The stock has a 52-week-high of $66.00 and a 52-week-low of $38.24. East West Bancorp's stock last closed at $39.91 per share.
Credit Suisse changed the rating for Holly Energy Partners LP (NYSE:HEP) from Neutral to Underperform. Holly Energy Partners earned $0.43 in the second quarter, compared to $0.38 in the year-ago quarter. The total market value of Holly Energy Partners's outstanding shares is at $2.8 billion. The stock has a 52-week-high of $33.40 and a 52-week-low of $26.33. Holly Energy Partners's stock last closed at $27.47 per share.

Initiations

With a rating of Buy, Needham initiated coverage on ACM Research Inc (NASDAQ:ACMR). The price target is set at $20.00 for ACM Research. For the second quarter, ACM Research had an EPS of $0.26, compared to year-ago quarter EPS of ($0.04). The stock has a 52-week-high of $21.88 and a 52-week-low of $9.02. ACM Research's stock last closed at $13.98 per share.
With a rating of Market Perform, Cowen & Co. initiated coverage on Albany International Corp (NYSE:AIN). The price target is set at $85.00 for Albany International. Albany International earned $1.09 in the second quarter, compared to $0.82 in the year-ago quarter. The total market value of Albany International's outstanding shares is at $2.6 billion. The stock has a 52-week-high of $86.97 and a 52-week-low of $58.06. Albany International's stock last closed at $82.66 per share.
Piper Jaffray initiated coverage on Advanced Micro Devices Inc (NASDAQ:AMD) with a Neutral rating. The price target for Advanced Micro Devices is set at $33.00. Advanced Micro Devices earned $0.08 in the second quarter, compared to $0.14 in the year-ago quarter. The total market value of Advanced Micro Devices's outstanding shares is at $30.3 billion. The stock has a 52-week-high of $35.55 and a 52-week-low of $16.03. Advanced Micro Devices's stock last closed at $31.18 per share.
Barclays initiated coverage on ConocoPhillips (NYSE:COP) with an Overweight rating. The price target for ConocoPhillips is set at $79.00. ConocoPhillips earned $1.01 in the second quarter, compared to $1.09 in the year-ago quarter. ConocoPhillips's market cap stands at $65.5 billion. The stock has a 52-week-high of $80.24 and a 52-week-low of $50.59. ConocoPhillips's stock last closed at $51.46 per share.
Baird initiated coverage on Castle Biosciences Inc (NASDAQ:CSTL) with an Outperform rating. The price target for Castle Biosciences is set at $27.00. The current market cap for Castle Biosciences is at $372.3 million. The stock has a 52-week-high of $24.75 and a 52-week-low of $17.11. Castle Biosciences's stock last closed at $20.25 per share.
SVB Leerink initiated coverage on Castle Biosciences Inc (NASDAQ:CSTL) with an Outperform rating. The price target for Castle Biosciences is set at $28.00. The total market value of Castle Biosciences's outstanding shares is at $372.3 million. The stock has a 52-week-high of $24.75 and a 52-week-low of $17.11. Castle Biosciences's stock last closed at $20.25 per share.
Canaccord Genuity initiated coverage on Castle Biosciences Inc (NASDAQ:CSTL) with a Buy rating. The price target for Castle Biosciences is set at $26.00. Castle Biosciences's market cap stands at $372.3 million. The stock has a 52-week-high of $24.75 and a 52-week-low of $17.11. Castle Biosciences's stock last closed at $20.25 per share.
With a rating of Buy, BTIG initiated coverage on Castle Biosciences Inc (NASDAQ:CSTL). The price target is set at $25.00 for Castle Biosciences. The current market cap for Castle Biosciences is at $372.3 million. The stock has a 52-week-high of $24.75 and a 52-week-low of $17.11. Castle Biosciences's stock last closed at $20.25 per share.
With a rating of Overweight, Barclays initiated coverage on Chevron Corp (NYSE:CVX). The price target is set at $145.00 for Chevron. Chevron earned $1.89 in the second quarter, compared to $1.78 in the year-ago quarter. Chevron's market cap stands at $237.0 billion. The stock has a 52-week-high of $127.60 and a 52-week-low of $100.22. Chevron's stock last closed at $115.78 per share.
Wells Fargo initiated coverage on Diodes Inc (NASDAQ:DIOD) with an Outperform rating. The price target for Diodes is set at $55.00. For the second quarter, Diodes had an EPS of $0.77, compared to year-ago quarter EPS of $0.58. The total market value of Diodes's outstanding shares is at $6.7 million. The stock has a 52-week-high of $44.27 and a 52-week-low of $27.38. Diodes's stock last closed at $37.60 per share.
H.C. Wainwright initiated coverage on Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) with a Buy rating. The price target for Entasis Therapeutics Hldg is set at $18.00. Entasis Therapeutics Hldg earned ($1.02) in the second quarter, compared to ($453.60) in the year-ago quarter. The stock has a 52-week-high of $13.70 and a 52-week-low of $3.97. Entasis Therapeutics Hldg's stock last closed at $8.15 per share.
Evercore ISI Group initiated coverage on Health Catalyst Inc (NASDAQ:HCAT) with an Outperform rating. The price target for Health Catalyst is set at $50.00. The total market value of Health Catalyst's outstanding shares is at $1.3 billion. The stock has a 52-week-high of $49.85 and a 52-week-low of $36.29. Health Catalyst's stock last closed at $42.38 per share.
With a rating of Buy, SunTrust Robinson Humphrey initiated coverage on Health Catalyst Inc (NASDAQ:HCAT). The price target is set at $53.00 for Health Catalyst. The total market value of Health Catalyst's outstanding shares is at $1.3 billion. The stock has a 52-week-high of $49.85 and a 52-week-low of $36.29. Health Catalyst's stock last closed at $42.38 per share.
With a rating of Outperform, SVB Leerink initiated coverage on Health Catalyst Inc (NASDAQ:HCAT). The price target is set at $55.00 for Health Catalyst. Health Catalyst's market cap stands at $1.3 billion. The stock has a 52-week-high of $49.85 and a 52-week-low of $36.29. Health Catalyst's stock last closed at $42.38 per share.
William Blair initiated coverage on Health Catalyst Inc (NASDAQ:HCAT) with an Outperform rating. Health Catalyst's market cap stands at $1.3 billion. The stock has a 52-week-high of $49.85 and a 52-week-low of $36.29. Health Catalyst's stock last closed at $42.38 per share.
Piper Jaffray initiated coverage on Health Catalyst Inc (NASDAQ:HCAT) with an Overweight rating. The price target for Health Catalyst is set at $47.00. Health Catalyst's market cap stands at $1.3 billion. The stock has a 52-week-high of $49.85 and a 52-week-low of $36.29. Health Catalyst's stock last closed at $42.38 per share.
With a rating of Overweight, JP Morgan initiated coverage on Health Catalyst Inc (NASDAQ:HCAT). The price target is set at $50.00 for Health Catalyst. Health Catalyst's market cap stands at $1.3 billion. The stock has a 52-week-high of $49.85 and a 52-week-low of $36.29. Health Catalyst's stock last closed at $42.38 per share.
With a rating of Buy, Goldman Sachs initiated coverage on Health Catalyst Inc (NASDAQ:HCAT). The price target is set at $49.00 for Health Catalyst. The total market value of Health Catalyst's outstanding shares is at $1.3 billion. The stock has a 52-week-high of $49.85 and a 52-week-low of $36.29. Health Catalyst's stock last closed at $42.38 per share.
With a rating of Overweight, Barclays initiated coverage on Hess Corp (NYSE:HES). The price target is set at $93.00 for Hess. In the second quarter, Hess showed an EPS of ($0.09), compared to ($0.23) from the year-ago quarter. The current market cap for Hess is at $2.3 billion. The stock has a 52-week-high of $74.81 and a 52-week-low of $35.59. Hess's stock last closed at $59.85 per share.
Barclays initiated coverage on JD.com Inc (NASDAQ:JD) with a Equal-Weight rating. The price target for JD.com is set at $36.00. JD.com earned $0.33 in the first quarter, compared to $0.11 in the year-ago quarter. The total market value of JD.com's outstanding shares is at $56.7 billion. The stock has a 52-week-high of $33.60 and a 52-week-low of $19.21. JD.com's stock last closed at $31.29 per share.
With a rating of Overweight, Piper Jaffray initiated coverage on Livongo Health Inc (NASDAQ:LVGO). The price target is set at $40.00 for Livongo Health. The total market value of Livongo Health's outstanding shares is at $3.0 billion. The stock has a 52-week-high of $45.68 and a 52-week-low of $31.60. Livongo Health's stock last closed at $36.79 per share.
With a rating of Equal-Weight, Morgan Stanley initiated coverage on Livongo Health Inc (NASDAQ:LVGO). The price target is set at $42.00 for Livongo Health. The current market cap for Livongo Health is at $3.0 billion. The stock has a 52-week-high of $45.68 and a 52-week-low of $31.60. Livongo Health's stock last closed at $36.79 per share.
With a rating of Outperform, SVB Leerink initiated coverage on Livongo Health Inc (NASDAQ:LVGO). The price target is set at $50.00 for Livongo Health. Livongo Health's market cap stands at $3.0 billion. The stock has a 52-week-high of $45.68 and a 52-week-low of $31.60. Livongo Health's stock last closed at $36.79 per share.
Needham initiated coverage on Livongo Health Inc (NASDAQ:LVGO) with a Buy rating. The price target for Livongo Health is set at $42.00. The total market value of Livongo Health's outstanding shares is at $3.0 billion. The stock has a 52-week-high of $45.68 and a 52-week-low of $31.60. Livongo Health's stock last closed at $36.79 per share.
With a rating of Overweight, KeyBanc initiated coverage on Livongo Health Inc (NASDAQ:LVGO). The price target is set at $46.00 for Livongo Health. The current market cap for Livongo Health is at $3.0 billion. The stock has a 52-week-high of $45.68 and a 52-week-low of $31.60. Livongo Health's stock last closed at $36.79 per share.
With a rating of Buy, Goldman Sachs initiated coverage on Livongo Health Inc (NASDAQ:LVGO). The price target is set at $43.00 for Livongo Health. The total market value of Livongo Health's outstanding shares is at $3.0 billion. The stock has a 52-week-high of $45.68 and a 52-week-low of $31.60. Livongo Health's stock last closed at $36.79 per share.
With a rating of Buy, Canaccord Genuity initiated coverage on Livongo Health Inc (NASDAQ:LVGO). The price target is set at $46.00 for Livongo Health. The current market cap for Livongo Health is at $3.0 billion. The stock has a 52-week-high of $45.68 and a 52-week-low of $31.60. Livongo Health's stock last closed at $36.79 per share.
With a rating of Overweight, JP Morgan initiated coverage on Livongo Health Inc (NASDAQ:LVGO). The price target is set at $43.00 for Livongo Health. The current market cap for Livongo Health is at $3.0 billion. The stock has a 52-week-high of $45.68 and a 52-week-low of $31.60. Livongo Health's stock last closed at $36.79 per share.
With a rating of Buy, H.C. Wainwright initiated coverage on Miragen Therapeutics Inc (NASDAQ:MGEN). The price target is set at $3.00 for Miragen Therapeutics. In the second quarter, Miragen Therapeutics showed an EPS of ($0.29), compared to ($0.29) from the year-ago quarter. The stock has a 52-week-high of $6.43 and a 52-week-low of $0.78. Miragen Therapeutics's stock last closed at $0.91 per share.
SVB Leerink initiated coverage on Myovant Sciences Ltd (NYSE:MYOV) with an Outperform rating. The price target for Myovant Sciences is set at $26.00. In the first quarter, Myovant Sciences showed an EPS of ($0.89), compared to ($0.98) from the year-ago quarter. Myovant Sciences's market cap stands at $1.2 billion. The stock has a 52-week-high of $27.45 and a 52-week-low of $6.60. Myovant Sciences's stock last closed at $6.93 per share.
With a rating of Buy, H.C. Wainwright initiated coverage on NuCana PLC (NASDAQ:NCNA). The price target is set at $20.00 for NuCana. NuCana earned ($0.17) in the first quarter, compared to ($0.27) in the year-ago quarter. NuCana's market cap stands at $290.1 million. The stock has a 52-week-high of $30.10 and a 52-week-low of $6.80. NuCana's stock last closed at $6.98 per share.
JP Morgan initiated coverage on Sunnova Energy International Inc (NYSE:NOVA) with an Overweight rating. The price target for Sunnova Energy Intl is set at $18.00. The total market value of Sunnova Energy Intl's outstanding shares is at $935.0 million. The stock has a 52-week-high of $12.00 and a 52-week-low of $10.51. Sunnova Energy Intl's stock last closed at $11.02 per share.
With a rating of Buy, Goldman Sachs initiated coverage on Sunnova Energy International Inc (NYSE:NOVA). The price target is set at $16.00 for Sunnova Energy Intl. The total market value of Sunnova Energy Intl's outstanding shares is at $935.0 million. The stock has a 52-week-high of $12.00 and a 52-week-low of $10.51. Sunnova Energy Intl's stock last closed at $11.02 per share.
Bank of America initiated coverage on Sunnova Energy International Inc (NYSE:NOVA) with a Buy rating. The price target for Sunnova Energy Intl is set at $15.00. Sunnova Energy Intl's market cap stands at $935.0 million. The stock has a 52-week-high of $12.00 and a 52-week-low of $10.51. Sunnova Energy Intl's stock last closed at $11.02 per share.
Raymond James initiated coverage on NXP Semiconductors NV (NASDAQ:NXPI) with an Outperform rating. The price target for NXP Semiconductors is set at $115.00. NXP Semiconductors earned $1.91 in the second quarter, compared to $1.50 in the year-ago quarter. The current market cap for NXP Semiconductors is at $27.0 billion. The stock has a 52-week-high of $108.51 and a 52-week-low of $67.62. NXP Semiconductors's stock last closed at $103.56 per share.
Barclays initiated coverage on Occidental Petroleum Corp (NYSE:OXY) with a Equal-Weight rating. The price target for Occidental Petroleum is set at $61.00. For the second quarter, Occidental Petroleum had an EPS of $0.97, compared to year-ago quarter EPS of $1.10. The total market value of Occidental Petroleum's outstanding shares is at $20.2 billion. The stock has a 52-week-high of $83.35 and a 52-week-low of $43.08. Occidental Petroleum's stock last closed at $44.66 per share.
Barclays initiated coverage on Pinduoduo Inc (NASDAQ:PDD) with an Overweight rating. The total market value of Pinduoduo's outstanding shares is at $25.7 billion. The stock has a 52-week-high of $31.99 and a 52-week-low of $16.53. Pinduoduo's stock last closed at $25.01 per share.
With a rating of Buy, Bank of America initiated coverage on ProSight Global Inc (NYSE:PROS). The price target is set at $23.00 for ProSight Global. The current market cap for ProSight Global is at $733.1 million. The stock has a 52-week-high of $20.20 and a 52-week-low of $15.75. ProSight Global's stock last closed at $18.71 per share.
SunTrust Robinson Humphrey initiated coverage on ProSight Global Inc (NYSE:PROS) with a Buy rating. The price target for ProSight Global is set at $25.00. ProSight Global's market cap stands at $733.1 million. The stock has a 52-week-high of $20.20 and a 52-week-low of $15.75. ProSight Global's stock last closed at $18.71 per share.
With a rating of Outperform, Keefe Bruyette & Woods initiated coverage on ProSight Global Inc (NYSE:PROS). The price target is set at $26.00 for ProSight Global. The total market value of ProSight Global's outstanding shares is at $733.1 million. The stock has a 52-week-high of $20.20 and a 52-week-low of $15.75. ProSight Global's stock last closed at $18.71 per share.
Barclays initiated coverage on ProSight Global Inc (NYSE:PROS) with an Overweight rating. The price target for ProSight Global is set at $23.00. The current market cap for ProSight Global is at $733.1 million. The stock has a 52-week-high of $20.20 and a 52-week-low of $15.75. ProSight Global's stock last closed at $18.71 per share.
Goldman Sachs initiated coverage on ProSight Global Inc (NYSE:PROS) with a Neutral rating. The price target for ProSight Global is set at $20.00. The current market cap for ProSight Global is at $733.1 million. The stock has a 52-week-high of $20.20 and a 52-week-low of $15.75. ProSight Global's stock last closed at $18.71 per share.